M&A Deal Summary

SmithRx Acquires WheitWell Rx

On January 10, 2017, SmithRx acquired life science company WheitWell Rx

Acquisition Highlights
  • This is SmithRx’s 1st transaction in the Life Science sector.
  • This is SmithRx’s 1st transaction in the United States.
  • This is SmithRx’s 1st transaction in New Jersey.

M&A Deal Summary

Date 2017-01-10
Target WheitWell Rx
Sector Life Science
Buyer(s) SmithRx
Deal Type Add-on Acquisition

Target

WheitWell Rx

Teaneck, New Jersey, United States
WhiteWell Rx is a provider of prescription drug management services for employer-based drug plans through a network of more than 65,000 retail, specialty and mail order pharmacies.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

SmithRx

San Francisco, California, United States

Category Company
Sector Business Services
DESCRIPTION

SmithRx is a pharmacy benefit manager focused on transparency, efficiency and data analytics. The proprietary technology infrastructure provides real-time actionable insights that drives cost savings, powers clinical services and results in a brilliant member experience.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2017 M&A 1 of 1